SY
Synairgen plc
SYGGF · OTC
$0.00 +0.00% (+$0.00)
Market Cap £81.9K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0001
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SYGGF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.01x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 44.64%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 151.29%
Asset turnover 0.00x
ROA 87.07%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.94x
Int. coverage N/A
Stability
35 /100
Moderate Beta 7.15x
Profitable years 0
EPS volatility 23.07%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SYGGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph Tregonning Colliver
Employees
34
Headquarters
Southampton
Upcoming events
24 SEP
Earnings
Upcoming earnings report